NMT200 Midterm Flashcards
goals of therapy in obesity
- overall, aim to reduce body fat for health by 5-10% for health benefits
- stabilize and prevent further weight gain
- prevent weight regain
- prevent and treat obesity-related comorbidities/complications
drugs associated with weight gain
- antidepressants (particularly tricyclic antidepressants)
- antipsychotics - first and second generations
- corticosteroids (ex. prednisone)
- antihyperglycemic drugs (sulfonylureas, meglitinides, thiazolidinediones); insulin
- lithium
which drugs are most likely to cause the greatest increase in weight gain
insulin
antipsychotics
lithium
T/F: lifestyle modification alone is superior to lifestyle modification and anti-obesity therapy
false: lifestyle modification and anti-obesity therapy together is superior
drugs that fall into the appetite suppressant category
bupropion alone
bupropion in combination with naltrexone
what other indications are there for bupropion?
antidepressant
smoking cessation aid
alcohol abuse disorder
indication for bupropion/naltrexone combination
indicated for weight management alongside diet and exercise for those with BMI of 30 or higher (27 if weight-related comorbidity present)
- mediates hormones involved in appetite and reward
what are the other indications for naltrexone
anti-opioid medication
adverse effects of bupropion
dry mouth, constipation, agitation, insomnia, anxiety
higher doses: seizures (rare)
hepatic impairment (fibrotic changes)
adverse effects for bupropion/naltrexone combination
contraindications
n/v, constipation, headache, dizziness, insomnia, dry mouth
contrindicated with concurrent opioid therapy due to precipitation of opioid withdrawal - patients must be opioid free for 7 days prior to initiation of treatment
avoid using bupropion with:
avoid concurrent use of drugs that lower seizure threshold
minimize/avoid alcohol
consuming with high-fat meal
uncontrolled hypertension, seizure disorder, severe hepatic impairment, end-stage renal failure
what drug for obesity falls into the class of lipase inhibitors?
orlistat
orlistat mechanism of action
gastric and pancreatic lipase inhibitor that reduced dietary fat absorption by 30%
orlistat adverse effects
contraindications
oily spotting, flatus with discharge, fecal urgency
decreased absorption of fat-soluble vitamins
contraindicated: chronic malabsorption syndrome or cholestasis
orlistat cautions
advise to take multivitamin daily at least 2 hrs before/after orlistat/at bedtime
high fat intake is poorly tolerated
less effective in patients on low fat diets
what are the major incretin hormones in humans?
what do they have in common re: metabolism?
GLP-1 and GIP (glucose dependent insulinotropic polypeptide)
they are responsible for most of the glucose-induced insulin secretory response following ingestion of glucose
both are metabolized by the enzyme dipeptidyl peptidase 4 (DPP4)
mechanism of action for incretin mimetics
GLP-1 - reduction of food intake and appetite, increased satiety, decreased gastric emptying, and affects reward-related systems in the brain
GIP has less effect on other organs, delays gastric emptying, plays a role where fat is depositied
what class of drugs does liraglutide fit into
incretin mimetic - a GLP-1 agonist
liraglutide:
administration
indications
administered via subcutaneous injection DAILY
indicated: type 2 diabetes, weight loss
liraglutide adverse effects
most common: n/v, constipation, diarrhea
GI side effects can be minimized in slow titration of dose
can cause pancreatitis in rare instances
severe hypoglycemia in patients with T2D
cautions of taking liraglutide
- in patients with heart rhythm disturbances, hepatic insufficiency, severe renal impairment
- should not be used in IBD (slows gastric emptying)
contraindications of liraglutide
pregnancy, breastfeeding
personal or family history of medullary thyroid carcinoma or multiple neoplasia syndrome type 2 (MEN2)
when to discontinue liraglutide in obesity
after 12 weeks if body weight loss is <5%
what class of obesity drugs does semaglutide fall into?
mechanism of action?
incretin mimetics - is a GLP-1 agonist like liraglutide
how is semaglutide different from liraglutide?
both GLP-1 agonists, subcutaneous
semaglutide has a longer half life so only needs to be administered once/week
adverse effects of semaglutide
n/v diarrhea, abdominal pain, constipation, digestive upset, fatigue, dizziness
increase in amylase and lipase - suggests possible pancreatitis
what is the general advice for weight loss during pregnancy?
despite increased risks to mother and infant, weight loss during pregnancy is not recommended
consensus is to counsel regarding weight gain targets during pregnancy
none of these drugs have evidence for safe use during pregnancy
which weight loss drugs are not recommended during pregnancy specifically?
which drug has conflicting evidence?
orlistat is not recommended because of reduced fat soluble vitamin absorption
evidence for bupropion is conflicting - it should not necessarily be discontinued if patient is already taking it pre-conception and if the therapy is needed
what is important to remember about the STEP 5 trial?
- compared semaglutide to placebo for obesity, but the placebo wasn’t a true placebo because it included lifestyle interventions
- the papers discuss the absolute weight change in the drug group (15%) but the actual MEAN change in weight in the drug group was 12%
- adverse effects: pancreatitis not present but lab values increasing towards pancreatitis
- subjects were mostly white women, middle aged
what classes of drugs can cause dyslipidema
- beta blockers (ending in -olol)
- corticosteroids (prednisone)
- HMG CoA Reductase Inhibitors (statins)
- thiazide or loop diuretics: hydrochlorothiazide, furosemide
- protease antiviral medications
- second generation antipsychotics: olanzapine, quetiapine
goals of therapy in drugs for diabetes
control symptoms
maintain glycemic control, avoid hypoglycemia
prevent/minimize risk of complications
achieve optimal control of risk factors (hypertension, obesity, dyslipidemia)
where is insulin sourced from when used as a therapy for diabetes? why
- most options are lab derived insulin, or human insulin analogues since they cause less antibody generation and adverse effects
what is meant by onset of action and duration of action of insulin in terms of diabetes management
rapid onset insulin preparation: useful for postprandial insulin injections or use with an insulin pump (continuous infusion)
long acting insulin preparations: useful for basal insulin infusion
adverse effects of insulin medication in diabetes
hypoglycemia - most common due due missed meals or increase in exercise
localized fat hypertrophy
allergic reactions - usually animal insulin
what drug class does metforin fall into?
biguanides
it is the only drug in this class
metformin mechanism of action
decreases hepatic glucose production
not associated with weight gain
adverse effects of taking metformin
nausea, diarrhea, abdominal discomfort, anorexia, metallic taste
lactic acidosis in cases of existing hepatic or renal disease (contraindicated)
vitamin B12 deficiency with long-term use
risk of hypoglycemia is low when used as monotherapy